Dr. Paul Corkery:

With respect, we have 22 various stakeholder groups in relation to this legislation on veterinary medicines, which we are bringing on and advancing. One of the key reasons we did not have a meeting with the antiparasitic stakeholder group is that a delegated Act on good distribution practice is about to go through. It has only just gone through and we are waiting for the scrutiny period to expire. Until now, medicines were regulated in terms of good distribution practice up to the wholesaler level. It is now extending right through to the farm, therefore, there are changes that are relevant. We did not really have anything new since April to bring to the group, if that answers the Senator's question. I will hand over to my colleague on the NVPS.